A new miniature pacemaker can now be used by patients in Canada. A heart pacemaker with a life of three years made of epoxy resin powered by mercury battery cells. Made by Godart NV a subsidiary of ...

A new, tiny pacemaker — smaller than a grain of rice — developed at Northwestern University near Chicago could play a sizeable role in the future of medicine, according to the engineers who developed ...

Recycled pacemakers can function as well as new devices, a University of Michigan-led study suggests. These used and reconditioned devices have the potential to increase access to pacemaker therapy in ...

In a breakthrough that could greatly ease the burden for patients recovering from cardiac surgery, scientists have developed a new type of temporary pacemaker that never needs to be removed. The world ...

Procedure-related infection rates were similar with reconditioned and new pacemakers, according to late-breaking research presented in a Hot Line session today at ESC Congress 2025. Explaining the ...

Recycled pacemakers can function as well as new devices, according to a new study. These used and reconditioned devices have the potential to increase access to pacemaker therapy in low- and ...

Fun fact: Your heart doesn’t need a brain, or a body for that matter, to beat. That’s because it has its own electrical system independent of your nervous system. However, the heart’s beating can go ...

CHICAGO, Nov. 17, 2024 — A randomized trial that compared previously used and new pacemakers in patients found the reconditioned devices were as safe and effective as new pacemakers, potentially ...

A new injectable, temporary pacemaker could help correct a heart arrhythmia in an emergency. This nanoparticle gel can regulate the heart’s electrical signals for up to five days before dissolving ...

Procedure-related infection rates were similar to reconditioned and new pacemakers, according to late-breaking research presented in a Hot Line session at the ESC Congress 2025. Subscribe to our ...

ABBOTT PARK, Ill., Nov. 12, 2021 /PRNewswire/ -- Abbott (NYSE: ABT) today announced new, late-breaking data from the global Leadless II IDE study evaluating Abbott's investigational Aveir leadless ...